Non-Interventional Study to Review the Changes of Depression after First-Year of Tofacitinib Treatment in Rheumatoid Arthritis (XELJANZ®) First published 01/04/2021 Last updated 05/02/2025 EU PAS number:EUPAS40263 Study Finalised